Type to search

Neurimmune Expands Drug Discovery Collaboration with Ono Pharmaceutical in the Field of Neurodegenerative Diseases | Pharmtech Focus
Neurimmune Enters into a Collaboration and License Agreement with AstraZeneca to Develop and Commercialize NI006 | Pharmtech Focus
FDA Approval of Aducanumab | Pharmtech Focus